For in vitro research and laboratory use only. Not for human consumption, diagnosis, or treatment.Terms
Retatrutide
Retatrutide (LY3437943) is a triple GLP-1/GIP/Glucagon receptor agonist. Phase 3 TRIUMPH-1 trial delivered 28.3% average weight loss at 80 weeks with the 12mg dose — the highest ever recorded in a Phase 3 obesity trial. Research compound for metabolic and endocrine studies. Molecular formula: C735H1116N180O172S4. CAS: 2381088-83-1.
Research use only. For in vitro research and laboratory use only. Not for human consumption, diagnosis, or treatment.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
From €83.00
Retatrutide—
€83.00